Please register or sign in to access the course content.
A 45-year-old man with a longstanding hereditary myopathic disorder was referred for cardiology evaluation prior to initiation of mexiletine therapy for disabling myotonia associated with dysphagia and gait impairment. He had no prior cardiovascular history and was clinically euthyroid with normal metabolic parameters. Baseline electrocardiography was obtained to assess conduction status before initiation of sodium channel blockade. Transthoracic echocardiography demonstrated structurally normal cardiac chambers with preserved biventricular systolic function. Ambulatory Holter monitoring showed no pauses, advanced atrioventricular block, or sustained tachyarrhythmias. Given the recognized association between certain neuromuscular disorders and progressive conduction system disease, specialized arrhythmic risk stratification was undertaken prior to initiation of sodium channel blockade.

Please register or sign in to access the course content.